Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS)
Funding Amounts: No budget limit; project period up to 5 years (R01 mechanism); budgets must reflect actual project needs.
Summary: Supports multidisciplinary bioengineering research integrating life and physical sciences to develop, optimize, and translate innovative tools, methods, or techniques for biomedical problems; clinical trials are not allowed.
Key Information: Applications requesting ≥$500,000 direct costs in any year require prior NIH program contact at least 6 weeks before submission.
This opportunity from the National Institutes of Health (NIH) supports multidisciplinary research projects that apply bioengineering approaches to address significant biomedical problems. The program encourages collaborations between life sciences and physical sciences (including engineering, mathematics, computer science, and related fields) to develop, integrate, optimize, validate, or accelerate the adoption of innovative tools, methods, and techniques for basic, translational, or clinical research and practice.
Projects may be design-directed, developmental, discovery-driven, or hypothesis-driven, and are suitable for small teams using integrative approaches. The focus is on advancing technologies or methods that address unmet needs or specific research/clinical problems, with the potential to enhance understanding of health and disease or improve medical practice. Clinical trials are not permitted under this funding opportunity.
All applications are due by 5:00 PM local time of the applicant organization. Standard NIH R01 due dates apply; see the NIH due dates page for future cycles.
Eligible applicants include:
Individuals: Any qualified individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Program Director/Principal Investigator (PD/PI) may apply.
Topic/Institute | Name | Phone | |
---|---|---|---|
General Grants Info | NIH Grants Information | GrantsInfo@nih.gov | 301-945-7573 |
Cancer Control/Population Sciences | Rao Divi, Ph.D. (NCI) | divir@mail.nih.gov | 240-276-6913 |
Cancer Biology | David Jonathan Miller, Ph.D. (NCI) | david.miller3@nih.gov | 240-276-6810 |
Other Cancer | Miguel R. Ossandon, Ph.D. (NCI) | ossandom@mail.nih.gov | 240-276-5714 |
Child Health | Toyin Ajisafe, Ph.D. (NICHD) | toyin.ajisafe@nih.gov | 301-827-9242 |
Eye Research | Tony Douglas Gover (NEI) | tony.gover@nih.gov | 301-529-7370 |
Dental/Craniofacial | Orlando Lopez, Ph.D. (NIDCR) | orlando.lopez@nih.gov | 301-402-4243 |
Neurological Disorders | Doe Kumsa, Ph.D. (NINDS) | doe.kumsa@nih.gov | 301-827-5832 |
Musculoskeletal/Skin | Xincheng (Ted) Zheng, M.D., Ph.D. (NIAMS) | zhengx4@mail.nih.gov | 301-594-4953 |
Deafness/Communication | Nancy Freeman, Ph.D. (NIDCD) | freemann@mail.nih.gov | 301-402-3458 |
For additional contacts (peer review, financial/grants management), see the full announcement Section VII.